scPharmaceuticals Inc. - Neraca (Quarterly)

scPharmaceuticals Inc.
US ˙ NasdaqGS ˙ US8106481059

Talaan ng Balanse (Quarterly)

Neraca scPharmaceuticals Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 44 72 76 75 79 74 52 41 41 71 75 71 35 47 58 39 91 76 58 41
Change (%) 62.20 5.59 -1.14 5.81 -6.37 -30.48 -20.24 0.27 72.11 6.18 -5.44 -50.89 33.59 24.85 -34.12 137.60 -17.30 -23.94 -29.08
Assets Current 116 108 99 92 86 78 68 58 47 123 127 114 104 93 77 63 123 106 89 79
Change (%) -6.80 -8.12 -6.64 -6.51 -9.48 -12.84 -15.20 -18.47 161.42 2.72 -10.34 -8.13 -10.93 -17.66 -18.16 96.91 -14.17 -15.58 -11.89
Assets 117 109 100 94 88 79 69 59 48 124 127 114 106 94 78 65 125 108 91 80
Change (%) -6.76 -8.03 -6.66 -6.50 -9.70 -12.83 -14.12 -18.19 156.60 2.56 -10.36 -7.07 -10.95 -16.96 -16.57 91.07 -14.03 -15.40 -11.77
Liabilities 27 27 25 25 24 23 20 19 17 52 52 51 57 57 54 56 94 94 96 102
Change (%) -0.98 -7.81 -0.83 -0.61 -7.59 -13.59 -4.08 -7.56 199.38 -0.38 -1.59 12.24 0.54 -5.89 4.31 67.88 -0.17 2.01 5.70
Equity 90 82 76 69 63 56 49 40 31 72 76 63 49 37 25 9 31 13 -5 -21
Change (%) -8.51 -8.10 -8.57 -8.59 -10.52 -12.53 -18.09 -23.10 132.83 4.66 -16.33 -22.52 -24.27 -33.99 -62.35 231.99 -56.63 -138.49 315.76
Liabilities And Stock Equity 117 109 100 94 88 79 69 59 48 124 127 114 106 94 78 65 125 108 91 80
Change (%) -6.76 -8.03 -6.66 -6.50 -9.70 -12.83 -14.12 -18.19 156.60 2.56 -10.36 -7.07 -10.95 -16.96 -16.57 91.07 -14.03 -15.40 -11.77

Source: Capital IQ

Other Listings
DE:2SX € 4.66
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista